Cite
HARVARD Citation
Gowda, C. et al. (n.d.). Novel Casein Kinase II (CK2) inhibitor BMS-135 shows significant in vivo anti-leukemia effect. European journal of cancer. pp. S29-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gowda, C. et al. (n.d.). Novel Casein Kinase II (CK2) inhibitor BMS-135 shows significant in vivo anti-leukemia effect. European journal of cancer. pp. S29-. [Online].